Jamie A Cesaretti
Overview
Explore the profile of Jamie A Cesaretti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
636
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andreassen C, Rosenstein B, Kerns S, Ostrer H, De Ruysscher D, Cesaretti J, et al.
Radiother Oncol
. 2016 Jul;
121(3):431-439.
PMID: 27443449
Purpose: Several small studies have indicated that the ATM rs1801516 SNP is associated with risk of normal tissue toxicity after radiotherapy. However, the findings have not been consistent. In order...
2.
Tong C, Ko E, Sung M, Cesaretti J, Stock R, Packer S, et al.
PLoS One
. 2012 Jul;
7(6):e36979.
PMID: 22761653
Background: Preclinical data suggest that sunitinib enhances the efficacy of radiotherapy. We tested the combination of sunitinib and hypofractionated image-guided radiotherapy (IGRT) in a cohort of patients with historically incurable...
3.
Kao J, Cesaretti J, Stone N, Stock R
Curr Urol Rep
. 2011 Mar;
12(3):237-42.
PMID: 21399887
Current research in prostate brachytherapy focuses on five key concepts covered in this review. Transrectal ultrasound-guided prostate brachytherapy assisted by intraoperative treatment planning is the most advanced form of image-guided...
4.
Burri R, Ho A, Forsythe K, Cesaretti J, Stone N, Stock R
Int J Radiat Oncol Biol Phys
. 2010 Jan;
77(5):1315-21.
PMID: 20044216
Purpose: To evaluate retrospectively the biochemical outcomes of young men treated with low-dose-rate brachytherapy for prostate cancer. Methods And Materials: From 1990 to 2005, 1,665 men with clinically localized prostate...
5.
Stone N, Marshall D, Stone J, Cesaretti J, Stock R
J Urol
. 2009 Dec;
183(2):634-9.
PMID: 20018308
Purpose: We evaluated the effect of neoadjuvant hormonal therapy on urinary function in men with a prostate volume of 50 cc or greater undergoing prostate brachytherapy. Materials And Methods: A...
6.
Stone N, Cesaretti J, Rosenstein B, Stock R
Brachytherapy
. 2009 Nov;
9(2):114-8.
PMID: 19879812
Purpose: To investigate the morbidity of higher radiation doses in prostate cancer patients. Methods And Materials: Five hundred eighty-five men treated with seed implantation and external beam irradiation were followed...
7.
Stone N, Stock R, Cesaretti J, Unger P
Int J Radiat Oncol Biol Phys
. 2009 Jul;
76(2):355-60.
PMID: 19632069
Purpose: To determine factors that influence local control and systemic relapse in patients undergoing permanent prostate brachytherapy (PPB). Methods And Materials: A total of 584 patients receiving PPB alone or...
8.
Kao J, Packer S, Vu H, Schwartz M, Sung M, Stock R, et al.
Cancer
. 2009 Jun;
115(15):3571-80.
PMID: 19536893
Background: To determine the safety and maximum-tolerated dose of concurrent sunitinib and image-guided radiotherapy (IGRT) followed by maintenance sunitinib in oligometastastic patients. Methods: Eligible patients had 1 to 5 sites...
9.
Stock R, Cesaretti J, Hall S, Stone N
BJU Int
. 2009 Jun;
104(11):1631-6.
PMID: 19493260
Objective: To assess the outcomes for patients with Gleason score 8-10 prostate cancer treated with brachytherapy, external beam radiotherapy (EBRT) and hormonal therapy (HT). Patients And Methods: In all, 181...
10.
Ho A, Burri R, Cesaretti J, Stone N, Stock R
Int J Radiat Oncol Biol Phys
. 2009 Mar;
75(1):16-22.
PMID: 19289266
Purpose: To evaluate the influence of patient- and treatment-related factors on freedom from biochemical failure (FFbF) in patients with intermediate-risk prostate cancer. Methods And Materials: From a prospectively collected database...